Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo-pharma

Tag: aurobindo pharma

Read all Latest developments, information and news on and about Aurobindo-pharma - Page 12

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Dr Reddy's, Cipla, Aurobindo units recall products in US market

Kajal Rajput25 Oct 2022 5:13 PM IST

New Delhi: Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various...

US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics

Ruchika Sharma15 Oct 2022 1:30 PM IST

Novartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.

Meet 52 richest Indians in Pharma Healthcare domain

Farhat Nasim21 Sept 2022 7:33 PM IST

New Delhi: The pharmaceutical sector minted the most number of dollar billionaires with 36 entrepreneurs in the recently released IIFL Wealth Hurun...

Aurobindo Pharma plans to infuse around Rs 300 crore for biologics manufacturing facilities

Ruchika Sharma2 Sept 2022 12:11 PM IST

The board approved entering into contract manufacturing operations (CMO) for biologicals for effective utilisation of capacities.

Aurobindo Pharma subsidiary's plant gets one observation from USFDA

Kajal Rajput30 Aug 2022 12:23 PM IST

Hyderabad: Aurobindo Pharma on Monday said the US health regulator has issued one observation after inspecting a plant owned by its US-based unit. The...

Aurobindo Pharma arm bags USFDA nod for Medroxyprogesterone Acetate Injectable Suspension

Ruchika Sharma24 Aug 2022 12:25 PM IST

Hyderabad: Drugmaker, Aurobindo Pharma Limited, today announced that its wholly-owned subsidiary company, Eugia Pharma Specialties Limited, has...

USFDA nod to Aurobindo Pharma arm's Vasopressin Injection

Ruchika Sharma16 Aug 2022 3:58 PM IST

Hyderabad: Drugmaker, Aurobindo Pharma Limited, today announced that its wholly owned subsidiary company, Eugia Pharma Specialties Limited, has...

Aurobindo Pharma net profit falls by 32 percent to Rs 520.5 crore in Q1

Ruchika Sharma14 Aug 2022 10:00 AM IST

Hyderabad: Pharmaceutical company Aurobindo Pharma on Thursday said its consolidated net profit for the quarter ended June 30 was down by 32.4...

Aurobindo Pharma gets USFDA EIR for Hyderabad facility

Ruchika Sharma5 Aug 2022 2:09 PM IST

New Delhi: Aurobindo Pharma has recently announced that the company has received an Establishment Inspection Report (EIR) from the USFDA with...

Aurobindo Pharma gets 3 USFDA observations for Andhra Pradesh facility

Ruchika Sharma3 Aug 2022 1:10 PM IST

Hyderabad: Aurobindo Pharma has recently announced that the United States Food and Drug Administration (USFDA) has issued FORM 483 with 3 observations...

Aurobindo Pharma on track to develop complex products, expand global footprint

Ruchika Sharma11 July 2022 1:00 PM IST

The facility will start filing new injectable products in FY23 with earliest possible commercialisation in FY24, the drugmaker added.

Aurobindo Pharma arm bags USFDA okay for Triamcinolone Acetonide Injectable Suspension

Ruchika Sharma6 July 2022 4:00 PM IST

The product is being launched this month.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok